LIVECAST Markets Briefs Calendar Search

Research

AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Briefs Calendar Search AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive Account

Live News EQUITY FLASH M impact Sep 21, 2026, 01:32 AM UTC

Dexus says Keir Barnes to step down as CFO

Dexus says Keir Barnes will step down as chief financial officer.

SquawkNews Newsroom

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

DXS

Related stories

AFRM shares rise as CEO says AI won’t replace underwriters Affirm Holdings shares gained about 0.42% overnight after the company launched a transformer-based ML model for real-time underwriting. CEO Max Levchin said in an interview with CN M impact | EQUITY | Sep 21, 2026, 03:57 AM UTC Vobile rises on launch of AI content creation platform SeeBay Shares of Vobile Group rise 6.7% to HK$3.56, the highest since Sept. 7, after the company launched its AI content creation and global IP monetization platform SeeBay on Sept. 17. T M impact | EQUITY | Sep 21, 2026, 03:52 AM UTC Garment Mantra Lifestyle receives order worth 103.70 million rupees Garment Mantra Lifestyle Ltd said it has received an order worth 103.70 million rupees. M impact | EQUITY | Sep 21, 2026, 03:52 AM UTC New World Development wins nod for Shanghai REIT spin-off listing New World Development received Shanghai Stock Exchange acceptance for a proposed spin-off listing of NWD C-REIT, which comprises Shanghai K11 Art Mall and Shanghai K11 ATELIER NWT. M impact | EQUITY | Sep 21, 2026, 03:52 AM UTC Garment Mantra Lifestyle receives ₹103.70 million order M impact | EQUITY | Sep 21, 2026, 03:49 AM UTC Hansoh Pharma drug meets trial endpoints, shares jump Shares of Hansoh Pharmaceutical Group rose 4.3% to HK$35.76, their highest level since September 9, after the company said its phase III clinical trial of HS-10374 in treatment of M impact | EQUITY | Sep 21, 2026, 03:42 AM UTC

SQUAWK/NEWS

Live financial news for traders. Read the headline on screen or hear it through LiveCast while you stay on the trade.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

Product

Open LiveCast
Plans & Pricing
Institutional API
How LiveCast Works
Live Markets
Session Briefs
RSS Feed
Calendar
Search
Instrument directory

Research

Macro
Politics
Prediction Markets
AI Market Assistant
News Archive

For Traders

Market Movers
US Stocks
Why News Moves Markets
News for Traders
How to Trade the News
What Is an Audio Squawk?
Policy Calendar

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

Legal

Privacy Policy
Terms of Use

© 2026 SquawkNews SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.